<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01272687</url>
  </required_header>
  <id_info>
    <org_study_id>PD02/2011</org_study_id>
    <nct_id>NCT01272687</nct_id>
  </id_info>
  <brief_title>Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation</brief_title>
  <acronym>PadGau</acronym>
  <official_title>Epidemiological Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The genotype-phenotype correlation in patients with Parkinson's disease with specific
      mutations in the glucocerebrosidase gene (Gaucher gene) is known from own clinical
      experiences as well as from case reports in the literature. The epidemiological study will
      determine the frequency of heterozygous mutations in the glucocerebrosidase gene and
      correlate to the clinical onset and development by measuring and documenting severity of
      symptoms (e.g. cognitive deficits, L-dopa responsiveness, depression) in clinically
      well-characterized Parkinson's patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parkinson's disease (also known as Parkinson's, Parkinson disease, or PD) is a degenerative
      disorder of the central nervous system that impairs motor skills, cognitive processes, and
      other functions. The most obvious symptoms are motor-related, including tremor, rigidity,
      slowness of movement, and postural instability. Among non-motor symptoms are autonomic
      dysfunction and sensory and sleep difficulties. Cognitive and neurobehavioral problems,
      including dementia, are common in the advanced stages of the disease. PD usually appears
      around the age of 60, although there are young-onset cases.

      Gaucher's disease is a genetic disease in which a fatty substance (lipid) accumulates in
      cells and certain organs. Gaucher's disease is the most common of the lysosomal storage
      diseases. It is caused by a hereditary deficiency of the enzyme glucocerebrosidase (also
      known as acid β-glucosidase). The enzyme acts on a fatty substance glucocerebroside (also
      known as glucosylceramide). When the enzyme is defective, glucocerebroside accumulates,
      particularly in white blood cells (mononuclear leukocytes). Glucocerebroside can collect in
      the spleen, liver, kidneys, lungs, brain and bone marrow.

      Symptoms of Parkinson's syndrome in classical type 1 Gaucher patients were first
      systematically described in 1996. In GD patients, a marked heterogeneity is detected in terms
      of disease-causing mutations. In 17 Gaucher patients with symptoms of Parkinson's disease, 12
      different genotypes were sequenced and compared to other Parkinson's patients, a lower L-dopa
      responsiveness, a higher frequency of cortical dysfunction and a relatively early onset of
      the symptoms was described. Many of these Gaucher patients with clinical Parkinson's symptoms
      had a positive family history of Parkinson's disease among relatives with heterozygous
      mutations in the Gaucher gene that could be confirmed in systematic studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Idiopathic Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <description>all adult Patients at 18 years with a confirmed diagnosis of Parkinson's disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients with a confirmed diagnosis of Parkinson's disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients at 18 years old

          -  Patients with confirmed diagnosis of Parkinson's disease

          -  Signed informed consent

        Exclusion Criteria:

          -  Male or female patients being younger than 18 years old

          -  Patients without confirmed diagnosis of Parkinson's disease

          -  Missing signed informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arndt Rolfs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rostock, Albrecht-Kossel-Institute for Neuroregeneration</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arndt Rolfs, MD</last_name>
    <phone>49-381-494</phone>
    <phone_ext>9540</phone_ext>
    <email>arndt.rolfs@med.uni-rostock.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthias Wittstock, MD</last_name>
    <phone>49-381-494</phone>
    <phone_ext>4791</phone_ext>
    <email>matthias.wittstock@med.uni-rostock.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fachkrankenhaus für neurologische Akut- und Rehabilitationsmedizin</name>
      <address>
        <city>Bad Neustadt</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Hahne, MD</last_name>
      <phone>+49 9771</phone>
      <phone_ext>9080</phone_ext>
      <email>m.hahne.akut@neurologie-bad-neustadt.de</email>
    </contact>
    <investigator>
      <last_name>Matthias Hahne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Dresden Klinik für Neurologie</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Storch, MD</last_name>
      <phone>+49 351 458</phone>
      <phone_ext>2532</phone_ext>
      <email>Alexander.Storch@neuro.med.tu-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Mareike Fauser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Giessen, Department of Neurology</name>
      <address>
        <city>Giessen</city>
        <zip>35385</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Tanislav, MD</last_name>
      <phone>+49 641 9854</phone>
      <phone_ext>5372</phone_ext>
      <email>christian.tanislav@neuro.med.uni-giessen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Tanislav, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ernst-Moritz-Arndt-University of Greifswald, Department of Neurology</name>
      <address>
        <city>Greifswald</city>
        <zip>17489</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Kessler, MD</last_name>
      <phone>+49 3834</phone>
      <phone_ext>866800</phone_ext>
      <email>Kessler@uni-greifswald.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Kessler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätskrankenhaus Hamburg-Eppendorf, Department of Neurology</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Münchau, MD</last_name>
      <phone>+49 40 - 7410</phone>
      <phone_ext>50134</phone_ext>
      <email>muenchau@uke.uni-hamburg.de</email>
    </contact>
    <investigator>
      <last_name>Simone Zittel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Bewegungsstörungsambulanz</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Dierks</last_name>
      <phone>+49 511</phone>
      <phone_ext>5323670</phone_ext>
      <email>Dierks.Gabriele@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Dirk Dressler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexianer Krefeld GmbH, Krankenhaus Maria Hilf</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Jürgen von Giesen, MD</last_name>
      <phone>+49 2151 334</phone>
      <phone_ext>7156</phone_ext>
      <email>h-j.vgiesen@alexianer-krefeld.de</email>
    </contact>
    <investigator>
      <last_name>Hans-Jürgen von Giesen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gertrudis-Kliniken im Parkinson-Zentrum</name>
      <address>
        <city>Leun-Biskirchen</city>
        <zip>35638</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilona Csoti, MD</last_name>
      <phone>+49 6473-3050</phone>
      <email>Parkinson-Center@t-online.de</email>
    </contact>
    <investigator>
      <last_name>Ilona Csoti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurologischische Arztpraxis</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liane Hauk-Westerhoff, MD</last_name>
      <phone>+49 381 37555</phone>
      <phone_ext>224</phone_ext>
      <email>liane.hauk-westerhoff@nervenaerzte-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Liane Hauk-Westerhoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Rostock, Klinik für Neurologie</name>
      <address>
        <city>Rostock</city>
        <zip>18147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Wittstock, MD</last_name>
      <phone>+49 381 494</phone>
      <phone_ext>4791</phone_ext>
      <email>matthias.wittstock@med.uni-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Matthias Wittstock, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikverbund Südwest, Klinikum Sindelfingen-Böblingen</name>
      <address>
        <city>Sindelfingen</city>
        <zip>71085</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gay Arnold</last_name>
      <phone>+49 7031</phone>
      <phone_ext>982362</phone_ext>
      <email>neurologie.si@klinikverbund-suedwest.de</email>
    </contact>
    <investigator>
      <last_name>Gay Arnold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HANSE-Klinikum, Department of Neurology</name>
      <address>
        <city>Stralsund</city>
        <zip>18410</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörn Peter Sieb, MD</last_name>
      <phone>+49 3831 352</phone>
      <phone_ext>550</phone_ext>
      <email>j.sieb@klinikum-hst.de</email>
    </contact>
    <investigator>
      <last_name>Wael Marouf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Bocola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Ulm, Department of Neurology</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Kassubek, MD</last_name>
      <phone>+49 731 177</phone>
      <phone_ext>5210</phone_ext>
      <email>jan.kassubek@uni-ulm.de</email>
    </contact>
    <investigator>
      <last_name>Jan Kassubek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stiftung Deutsche Klinik für Diagnostik GmbH Fachbereich Neurologie</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65191</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Jost, MD</last_name>
      <phone>+49 611 577</phone>
      <phone_ext>652</phone_ext>
      <email>jost.neuro@dkd-wiesbaden.de</email>
    </contact>
    <investigator>
      <last_name>Natalie Hackert-Lust, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chulalongkorn University Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bhidayasiri Roongroj, MD</last_name>
      <phone>+662 256</phone>
      <phone_ext>4627</phone_ext>
      <email>rbh1@ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Bhidayasiri Roongroj, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Bras J, Singleton A, Cookson MR, Hardy J. Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease. FEBS J. 2008 Dec;275(23):5767-73. doi: 10.1111/j.1742-4658.2008.06709.x. Review.</citation>
    <PMID>19021754</PMID>
  </reference>
  <reference>
    <citation>Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 2007 Sep 18;69(12):1270-7.</citation>
    <PMID>17875915</PMID>
  </reference>
  <reference>
    <citation>Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T, Bar-Shira A, Orr-Urtreger A. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology. 2008 Jun 10;70(24):2277-83. doi: 10.1212/01.wnl.0000304039.11891.29. Epub 2008 Apr 23.</citation>
    <PMID>18434642</PMID>
  </reference>
  <reference>
    <citation>Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet. 2004 Dec;41(12):937-40.</citation>
    <PMID>15591280</PMID>
  </reference>
  <reference>
    <citation>Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett. 2009 Mar 13;452(2):87-9. doi: 10.1016/j.neulet.2009.01.029. Epub 2009 Jan 15.</citation>
    <PMID>19383421</PMID>
  </reference>
  <reference>
    <citation>Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998 Apr 9;392(6676):605-8.</citation>
    <PMID>9560156</PMID>
  </reference>
  <reference>
    <citation>Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J, Fukuda Y, Date H, Iwata A, Yamamoto M, Hattori N, Murata M, Toda T, Tsuji S. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol. 2009 May;66(5):571-6. doi: 10.1001/archneurol.2009.72.</citation>
    <PMID>19433656</PMID>
  </reference>
  <reference>
    <citation>Neudorfer O, Giladi N, Elstein D, Abrahamov A, Turezkite T, Aghai E, Reches A, Bembi B, Zimran A. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM. 1996 Sep;89(9):691-4.</citation>
    <PMID>8917744</PMID>
  </reference>
  <reference>
    <citation>Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 2009 Jul;132(Pt 7):1783-94. doi: 10.1093/brain/awp044. Epub 2009 Mar 13.</citation>
    <PMID>19286695</PMID>
  </reference>
  <reference>
    <citation>Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5.</citation>
    <PMID>18987351</PMID>
  </reference>
  <reference>
    <citation>Sidransky E. Gaucher disease: complexity in a &quot;simple&quot; disorder. Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15. Review.</citation>
    <PMID>15464415</PMID>
  </reference>
  <reference>
    <citation>Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009 Oct 22;361(17):1651-61. doi: 10.1056/NEJMoa0901281.</citation>
    <PMID>19846850</PMID>
  </reference>
  <reference>
    <citation>Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, Rosenbaum H, Schiffmann R, Bembi B, Sidransky E. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab. 2003 Jun;79(2):104-9.</citation>
    <PMID>12809640</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2011</study_first_submitted>
  <study_first_submitted_qc>January 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2011</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Arndt Rolfs</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>Parkinsonian Disorders</keyword>
  <keyword>Brain Diseases</keyword>
  <keyword>Central Nervous System Diseases</keyword>
  <keyword>Nervous System Diseases</keyword>
  <keyword>Neurodegenerative Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

